Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esha Sachdev

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Opinion on Investigational Drugs|August 29, 2017
Aldoxorubicin for the treatment of soft tissue sarcomaEsha Sachdev, Divesh Sachdev, Monica Mita
Cureus|February 27, 2016
A Rare Finding of a BRAF Mutation in Renal Cell Carcinoma with Response to BRAF-Directed Targeted TherapyNatasha Banerjee, Esha Sachdev, Robert A Figlin
Current Oncology Reports|June 6, 2015
Adnectin-targeted inhibitors: rationale and resultsEsha Sachdev, Jun Gong, Bobbie Rimel, et al.
The American Journal of Medicine|December 3, 2014
Left ventricular hypertrophy in valvular aortic stenosis: mechanisms and clinical implicationsFlorian Rader, Esha Sachdev, Reza Arsanjani, et al.
European Cardiology|October 13, 2018
Takotsubo CardiomyopathyEsha Sachdev, C Noel Bairey Merz, Puja K Mehta
World Journal of Methodology|March 29, 2016
Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activityJun Gong, Esha Sachdev, Alain C Mita, et al.
Targeted Oncology|October 19, 2019
PARP Inhibition in Cancer: An Update on Clinical DevelopmentEsha Sachdev, Roya Tabatabai, Varun Roy, et al.
Oncology Letters|April 30, 2017
Statins and pancreatic cancerJun Gong, Esha Sachdev, Lori A Robbins, et al.
Journal for Immunotherapy of Cancer|March 3, 2021
Considerations for treatment duration in responders to immune checkpoint inhibitorsThomas U Marron, Aideen E Ryan, Sangeetha M Reddy, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|August 29, 2017
Aldoxorubicin for the treatment of soft tissue sarcomaEsha Sachdev, Divesh Sachdev, Monica Mita
Cureus|February 27, 2016
A Rare Finding of a BRAF Mutation in Renal Cell Carcinoma with Response to BRAF-Directed Targeted TherapyNatasha Banerjee, Esha Sachdev, Robert A Figlin
Current Oncology Reports|June 6, 2015
Adnectin-targeted inhibitors: rationale and resultsEsha Sachdev, Jun Gong, Bobbie Rimel, et al.
The American Journal of Medicine|December 3, 2014
Left ventricular hypertrophy in valvular aortic stenosis: mechanisms and clinical implicationsFlorian Rader, Esha Sachdev, Reza Arsanjani, et al.
European Cardiology|October 13, 2018
Takotsubo CardiomyopathyEsha Sachdev, C Noel Bairey Merz, Puja K Mehta
World Journal of Methodology|March 29, 2016
Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activityJun Gong, Esha Sachdev, Alain C Mita, et al.
Targeted Oncology|October 19, 2019
PARP Inhibition in Cancer: An Update on Clinical DevelopmentEsha Sachdev, Roya Tabatabai, Varun Roy, et al.
Oncology Letters|April 30, 2017
Statins and pancreatic cancerJun Gong, Esha Sachdev, Lori A Robbins, et al.
Journal for Immunotherapy of Cancer|March 3, 2021
Considerations for treatment duration in responders to immune checkpoint inhibitorsThomas U Marron, Aideen E Ryan, Sangeetha M Reddy, et al.
Pageof 1